Defining the pathways activated by Toll-like Receptors to stimulate immunity
Defining the pathways activated by Toll-like Receptors to stimulate immunity
批准号:
10553667
负责人:
JONATHAN C KAGAN
金额:
$53.1万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
未结题
起止时间:
2016-12-13 至 2026-01-31
关键词:
Antitumor ResponseBiologyCD14 AntigenCD8-Positive T-LymphocytesCellsComplexCuriositiesDangerousnessDataDedicationsDendritic CellsDetectionEnzymesEventFamilyFundingGene ExpressionGenetic TranscriptionGlycolysisGlycolysis InductionGlycolysis PathwayGoalsGranulocyte-Macrophage Colony-Stimulating FactorImmune responseImmunityIn VitroInfectionInflammatoryInterferonsInvestigationKnowledgeLifeMAP Kinase GeneMacrophageMalignant NeoplasmsMedialMediatingMetabolicMicrobeMotionMusNF-kappa BPathway interactionsPhosphotransferasesProteinsReceptor SignalingRegulationResearch ProposalsRoleSignal PathwaySignal TransductionSiteStructureSystemT-LymphocyteTBK1 geneTLR3 geneTLR4 geneTRAF6 geneTissuesToll-Like Receptor PathwayToll-like receptorsTumor AntigensTumor ImmunityWorkadaptive immunityaerobic glycolysiscancer immunotherapyimmune activationin vitro activityinnate immune pathwaysinnovationnovelreceptorrecruitresponsescaffoldsynthetic biologytranscription factor
中文摘要
项目概要
该提案的目标是确定 Toll 样受体 (TLR) 如何刺激不同的细胞反应
巨噬细胞和树突状细胞 (DC),并了解这些反应如何影响基于 DC 的癌症
免疫疗法。 TLR 诱导炎症基因表达的能力已被研究
二十年来,MyD88 和 TRIF 适配器介导的不同信号通路解释了所有
转录反应。直到最近人们才认识到 TLR 也能驱动代谢变化
反应细胞,例如快速诱导有氧糖酵解。在上一个资助期间,我们
发现 TLR 诱导的 myddosome 复合物含有两类蛋白质。需要上一堂课
用于 myddosome 组装(例如 MyD88)并代表该信号传导结构的核心。第二类是
对于 myddosome 组装(例如 TRAF6)来说不是必需的,而是用于招募使细胞多样化的酶
myddosome 的效应器功能。具体来说,我们将激酶 TBK1 鉴定为 myddosome 成分
由 TRAF6 招募并专门用于诱导糖酵解。因此,myddosome 的作用是
作为激活不同细胞反应的信号的亚细胞位点。我们对这些活动的理解
在体外受到调节,它们对 T 细胞介导的保护性免疫的影响仍然有限。
除了 myddosome 之外,选择的 TLR(例如 TLR4 和 TLR3)也与三叶体结合。中央三体
TRIF 是一个调节因子,可刺激干扰素 (IFN) 反应、NF-kB 和 MAPK 激活、坏死性凋亡和
糖酵解。虽然 TRIF 在免疫中的重要性早已被认识到,但它激活的方式
这些不同的反应尚不清楚。这种知识差距不仅仅是学术上的好奇心,就像 TRIF 一样
对于 LPS 受体 TLR4 刺激适应性免疫的能力至关重要。了解监管
刺激 myddosome 和 TRIF 依赖性反应的事件将使人们能够讨论 TLR 如何驱动
针对感染和癌症的保护性免疫力。在此应用中,我们建议探索 myddosome
体外和癌症免疫治疗背景下的活动(目标 1)。在目标 2 中,我们提供了一种创新的合成材料
基于生物学的方法来定义 TRIF 信号传导机制以及这些机制如何与这些机制相关
由互补性先天免疫途径诱导。我们关注激活的两条主要信号通路
TLRs 的研究应该提供这个重要受体家族的操作视图。
英文摘要
Project Summary
The goal of this proposal is to identify how Toll-like Receptors (TLRs) stimulate diverse cellular responses in
macrophages and dendritic cells (DCs), and to understand how these responses influence DC-based cancer
immunotherapies. The ability of TLRs to induce inflammatory gene expression has been under investigation for
twenty years, with distinct signaling pathways mediated by the MyD88 and TRIF adaptors explaining all
transcriptional responses. It has only recently become appreciated that TLRs also drive metabolic changes in
responding cells, such as the rapid induction of aerobic glycolysis. During the previous funding period, we
discovered that the TLR-induced myddosome complex contains two classes of proteins. One class is necessary
for myddosome assembly (e.g. MyD88) and represents the core of this signaling structure. The second class is
not necessary for myddosome assembly (e.g. TRAF6), but rather operates to recruit enzymes that diversify the
effector functions of the myddosome. Specifically, we identified the kinase TBK1 as a myddosome component
that is recruited by TRAF6 and is dedicated specifically to induce glycolysis. The myddosome therefore serves
as a subcellular site of signals that activate diverse cellular responses. Our understanding of how these activities
are regulated in vitro and their impact on T cell mediated protective immunity remains limited.
In addition to the myddosome, select TLRs (e.g. TLR4 and TLR3) engage the triffosome. The central triffosome
regulator is TRIF, which stimulates interferon (IFN) responses, NF-kB and MAPK activation, necroptosis and
glycolysis. While the importance of TRIF in immunity has long-been recognized, the means by which it activates
these diverse responses is unclear. This gap in knowledge is not merely an academic curiosity, as TRIF is
essential for the ability of the LPS receptor TLR4 to stimulate adaptive immunity. Understanding regulatory
events that stimulate myddosome- and TRIF-dependent responses will enable discussions of how TLRs drive
protective immunity against infection and cancer. In this application, we propose to explore myddosome
activities in vitro and in the context of cancer immunotherapies (Aim 1). In Aim 2, we offer an innovative synthetic
biology-based approach to define the mechanisms of TRIF signaling and how these mechanisms relate to those
induced by complementary innate immune pathways. Our focus on the two major signaling pathways activated
by TLRs should provide an operational view of this important family of receptors.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulation of immunity by the cGAS-STING pathway
-
批准号:10583763
-
项目类别:
-
资助金额:$78.49万
-
财政年份:2022
-
负责人:JONATHAN C KAGAN
-
依托单位:
Regulation of immunity by the cGAS-STING pathway
-
批准号:10707202
-
项目类别:
-
资助金额:$78.93万
-
财政年份:2022
-
负责人:JONATHAN C KAGAN
-
依托单位:
Characterization of the myddosome, a protein complex that controls TLR signaling
-
批准号:9236656
-
项目类别:
-
资助金额:$44.25万
-
财政年份:2016
-
负责人:JONATHAN C KAGAN
-
依托单位:
Defining the pathways activated by Toll-like Receptors to stimulate immunity
-
批准号:10209029
-
项目类别:
-
资助金额:$53.1万
-
财政年份:2016
-
负责人:JONATHAN C KAGAN
-
依托单位:
Initiation and regulation of antibacterial innate immunity
-
批准号:8891586
-
项目类别:
-
资助金额:$45.58万
-
财政年份:2014
-
负责人:JONATHAN C KAGAN
-
依托单位:
Defining non-transcriptional innate immune responses to bacterial endotoxin
-
批准号:8660126
-
项目类别:
-
资助金额:$41.13万
-
财政年份:2013
-
负责人:JONATHAN C KAGAN
-
依托单位:
Initiation and Regulation of Antiviral Innate Immunity
-
批准号:8434005
-
项目类别:
-
资助金额:$40.89万
-
财政年份:2011
-
负责人:JONATHAN C KAGAN
-
依托单位:
Initiation and Regulation of Antiviral Innate Immunity
-
批准号:8223165
-
项目类别:
-
资助金额:$43.5万
-
财政年份:2011
-
负责人:JONATHAN C KAGAN
-
依托单位:
Initiation and Regulation of Antiviral Innate Immunity
-
批准号:8824865
-
项目类别:
-
资助金额:$43.5万
-
财政年份:2011
-
负责人:JONATHAN C KAGAN
-
依托单位:
Initiation and Regulation of Antiviral Innate Immunity
-
批准号:8081944
-
项目类别:
-
资助金额:$43.21万
-
财政年份:2011
-
负责人:JONATHAN C KAGAN
-
依托单位:
Initiation and Regulation of Antiviral Innate Immunity
-
批准号:10475431
-
项目类别:
-
资助金额:$53.1万
-
财政年份:2011
-
负责人:JONATHAN C KAGAN
-
依托单位:
Initiation and Regulation of Antiviral Innate Immunity
-
批准号:8610230
-
项目类别:
-
资助金额:$43.5万
-
财政年份:2011
-
负责人:JONATHAN C KAGAN
-
依托单位:
Cellular and molecular aspects of Toll-like receptor signal transduction.
-
批准号:7224426
-
项目类别:
-
资助金额:$9.0万
-
财政年份:2006
-
负责人:JONATHAN C KAGAN
-
依托单位:
Cellular and molecular aspects of Toll-like receptor signal transduction.
-
批准号:7569436
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2006
-
负责人:JONATHAN C KAGAN
-
依托单位:
Cellular and molecular aspects of Toll-like receptor signal transduction.
-
批准号:7531580
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2006
-
负责人:JONATHAN C KAGAN
-
依托单位:
Enrichment Program
-
批准号:10378469
-
项目类别:
-
资助金额:$8.7万
-
财政年份:1997
-
负责人:JONATHAN C KAGAN
-
依托单位:
Enrichment Program
-
批准号:10626005
-
项目类别:
-
资助金额:$8.7万
-
财政年份:1997
-
负责人:JONATHAN C KAGAN
-
依托单位:
Enrichment Program
-
批准号:10049389
-
项目类别:
-
资助金额:$8.7万
-
财政年份:1997
-
负责人:JONATHAN C KAGAN
-
依托单位:
国内基金
海外基金
Journal of Integrative Plant Biology
-
批准号:31024801
-
项目类别:专项基金项目
-
资助金额:24.0万元
-
批准年份:2010
-
负责人:贺萍
-
依托单位: